Hypernatremia and hypokalemia with Entrectinib therapy: A case of possible nephrogenic diabetes insipidus

Overview of attention for article published in Journal of Onco-Nephrology, January 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 1 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 3,677 followers.

RT @fadel_remy: Check out our very interesting case that reports hypoK and hyperNa in association with Entrectinib therapy with renal potas…

11 Mar 2023

Reply Repost Favourite

Check out our very interesting case that reports hypoK and hyperNa in association with Entrectinib therapy with renal potassium wasting and partial nephrogenic as possible pathophysiologic bases respectively. #onconephrology @JOncoNeph @AliMehdiMD https://

11 Mar 2023

Reply Repost Favourite

RT @onconephsociety: Hypernatremia and hypokalemia with Entrectinib therapy: A case of possible nephrogenic diabetes insipidus https://t.co…

29 Jan 2023

Reply Repost Favourite

RT @onconephsociety: Hypernatremia and hypokalemia with Entrectinib therapy: A case of possible nephrogenic diabetes insipidus https://t.co…

29 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.